Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial

Scott, DL; Ibrahim, F; Farewell, V; O'Keeffe, AG; Walker, D; Kelly, C; Birrell, F; Chakravarty, K; Maddison, P; Heslin, M; Patel, A; Kingsley, GH

View/Open

Published version (335.4Kb)

Volume

350

DOI

10.1136/bmj.h1046

Journal

BMJ-BRITISH MEDICAL JOURNAL

ISSN

1756-1833

Metadata

Show full item record

Authors

Scott, DL; Ibrahim, F; Farewell, V; O'Keeffe, AG; Walker, D; Kelly, C; Birrell, F; Chakravarty, K; Maddison, P; Heslin, M

URI

http://qmro.qmul.ac.uk/xmlui/handle/123456789/17628

Collections

Centre for Primary Care and Public Health [1467]

Licence information

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/ by-nc/4.0/.